Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupa Padaki

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
FEBS Open Bio|August 6, 2021
Fc glycan sialylation of biotherapeutic monoclonal antibodies has limited impact on antibody-dependent cellular cytotoxicityElaine Branstetter, Robert J Duff, Scott Kuhns, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 5, 2014
Mouse monoclonal antibodies to transient receptor potential ankyrin 1 act as antagonists of multiple modes of channel activationKi Jeong Lee, Weiya Wang, Rupa Padaki, et al.
Mabs|January 3, 2022
Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometryDaniel W Woodall, Thomas M Dillon, Kevin Kalenian, et al.
Cytokine|January 9, 2009
Differences in binding and effector functions between classes of TNF antagonistsTaruna Arora, Rupa Padaki, Ling Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2010
Molecular and functional characterization of cynomolgus monkey IgG subclassesFrederick W Jacobsen, Rupa Padaki, Arvia E Morris, et al.
Mabs|October 12, 2023
Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in miceShufang Liu, Sara C Humphreys, Kevin D Cook, et al.
Ophthalmology and Therapy|March 20, 2024
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference ProductNeungseon Seo, Xiaoyan Guan, Tian Wang, et al.
Frontiers in Immunology|December 31, 2021
Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and TargetMark A Kroenke, Troy E Barger, Jenny Hu, et al.
Mabs|September 12, 2023
Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodiesMarissa Mock, Alex W Jacobitz, Christopher James Langmead, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
FEBS Open Bio|August 6, 2021
Fc glycan sialylation of biotherapeutic monoclonal antibodies has limited impact on antibody-dependent cellular cytotoxicityElaine Branstetter, Robert J Duff, Scott Kuhns, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 5, 2014
Mouse monoclonal antibodies to transient receptor potential ankyrin 1 act as antagonists of multiple modes of channel activationKi Jeong Lee, Weiya Wang, Rupa Padaki, et al.
Mabs|January 3, 2022
Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometryDaniel W Woodall, Thomas M Dillon, Kevin Kalenian, et al.
Cytokine|January 9, 2009
Differences in binding and effector functions between classes of TNF antagonistsTaruna Arora, Rupa Padaki, Ling Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2010
Molecular and functional characterization of cynomolgus monkey IgG subclassesFrederick W Jacobsen, Rupa Padaki, Arvia E Morris, et al.
Mabs|October 12, 2023
Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in miceShufang Liu, Sara C Humphreys, Kevin D Cook, et al.
Ophthalmology and Therapy|March 20, 2024
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference ProductNeungseon Seo, Xiaoyan Guan, Tian Wang, et al.
Frontiers in Immunology|December 31, 2021
Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and TargetMark A Kroenke, Troy E Barger, Jenny Hu, et al.
Mabs|September 12, 2023
Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodiesMarissa Mock, Alex W Jacobitz, Christopher James Langmead, et al.
Pageof 1